6laf

Publication Abstract from PubMed

Akkermansia muciniphila is a beneficial microorganism colonized in the human gut that can reverse many intestinal metabolic-related diseases. Amuc_1100 is an outer-membrane protein of A. muciniphila. Oral administration of Amuc_1100 can reduce fat mass development, insulin resistance, and dyslipidemia in mice and activated the toll-like receptor 2 (TLR2) to regulate the immune response of the host, but the molecular mechanism remains unclear. Here we report the crystal structure of the extramembranous domain of Amuc_1100, which consists of a four-stranded antiparallel beta-sheet and four alpha-helices. Two C-terminal helices and the four-stranded antiparallel beta-sheet formed two "alphabetabeta" motifs and constituted the core domain, which shared a similar fold with type IV pili and type II Secretion system protein. Although the full-length of the extramembranous domain of Amuc_1100 existed as a monomer in solution, they formed trimer in the crystal. Elimination of the N-terminal coiled-coil helix alpha1 led to dimerization of Amuc_1100 both in solution and in crystal, indicating that the oligomeric state of Amuc_1100 was variable and could be influenced by alpha1. In addition, we identified that Amuc_1100 could directly bind human TLR2 (hTRL2) in vitro, suggesting that Amuc_1100 may serve as a new ligand for hTLR2. Dimerization of Amuc_1100 improved its hTLR2-binding affinity, suggesting that the alpha1-truncated Amuc_1100 could be a beneficial candidate for the development of A. muciniphila related drugs.

The variable oligomeric state of Amuc_1100 from Akkermansia muciniphila.,Wang J, Xiang R, Wang R, Zhang B, Gong W, Zhang J, Zhang M, Wang M J Struct Biol. 2020 Jul 28:107593. doi: 10.1016/j.jsb.2020.107593. PMID:32736072^[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.